Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
102M
-
Number of holders
-
57
-
Total 13F shares, excl. options
-
41.5M
-
Shares change
-
+4.52M
-
Total reported value, excl. options
-
$698M
-
Value change
-
+$75M
-
Number of buys
-
38
-
Number of sells
-
-9
-
Price
-
$16.85
Significant Holders of Day One Biopharmaceuticals, Inc. - COMMON STOCK (DAWN) as of Q4 2021
62 filings reported holding DAWN - Day One Biopharmaceuticals, Inc. - COMMON STOCK as of Q4 2021.
Day One Biopharmaceuticals, Inc. - COMMON STOCK (DAWN) has 57 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 41.5M shares
of 102M outstanding shares and own 40.67% of the company stock.
Largest 10 shareholders include Canaan Partners XI LLC (9.66M shares), Atlas Venture Life Science Advisors, LLC (8.2M shares), RA CAPITAL MANAGEMENT, L.P. (4.97M shares), VANGUARD GROUP INC (3.03M shares), FMR LLC (2.83M shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (2.2M shares), PRICE T ROWE ASSOCIATES INC /MD/ (1.58M shares), BOXER CAPITAL, LLC (1.19M shares), VIKING GLOBAL INVESTORS LP (1.16M shares), and JANUS HENDERSON GROUP PLC (1.02M shares).
This table shows the top 57 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.